Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Reported Scale vs CTCAE Grading for Reporting Chemotherapy Related Adverse Effects: A Prospective Comparator Study

NCT05158907 is registered in ClinicalTrials.gov with Tata Medical Center as lead sponsor.

NCT NCT05158907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05158907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Reported Scale vs CTCAE Grading for Reporting Chemotherapy Related Adverse Effects: A Prospective Comparator Study
Lead sponsor
Tata Medical Center
Phase
Not applicable
Overall status
Suspended
Start date
November 23, 2021
Completion date
February 28, 2024
Enrollment
220 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastrointestinal cancer